HSBC Holdings’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Buy
195,037
+12,170
+7% +$731K 0.01% 926
2025
Q4
$10.8M Sell
182,867
-23,634
-11% -$1.44M 0.01% 925
2025
Q3
$11.4M Sell
206,501
-19,630
-9% -$1.05M 0.01% 878
2025
Q2
$11.6M Sell
226,131
-299,993
-57% -$15.1M 0.01% 859
2025
Q1
$30.8M Buy
526,124
+257,652
+96% +$17.5M 0.02% 597
2024
Q4
$19.3M Buy
268,472
+21,483
+9% +$1.58M 0.01% 741
2024
Q3
$19.7M Sell
246,989
-44,817
-15% -$3.37M 0.01% 727
2024
Q2
$20.9M Sell
291,806
-25,264
-8% -$1.86M 0.01% 670
2024
Q1
$22.3M Buy
317,070
+55,700
+21% +$3.99M 0.02% 666
2023
Q4
$20.2M Buy
261,370
+93,107
+55% +$6.13M 0.02% 669
2023
Q3
$11.5M Sell
168,263
-67,546
-29% -$5.34M 0.01% 790
2023
Q2
$19.3M Sell
235,809
-20,808
-8% -$1.67M 0.02% 634
2023
Q1
$19M Sell
256,617
-34,029
-12% -$2.62M 0.02% 628
2022
Q4
$24M Buy
290,646
+181,266
+166% +$14.4M 0.03% 593
2022
Q3
$7.81M Sell
109,380
-10,364
-9% -$896K 0.01% 998
2022
Q2
$10.4M Buy
119,744
+396
+0.3% +$37.1K 0.01% 875
2022
Q1
$13.1M Sell
119,348
-69,780
-37% -$7.2M 0.02% 771
2021
Q4
$24.4M Buy
189,128
+75,928
+67% +$9.31M 0.02% 613
2021
Q3
$13.8M Buy
113,200
+81,764
+260% +$9.95M 0.01% 753
2021
Q2
$3.53M Buy
31,436
+14,364
+84% +$1.51M ﹤0.01% 1226
2021
Q1
$1.62M Sell
17,072
-37,964
-69% -$3.46M ﹤0.01% 1378
2020
Q4
$4.37M Buy
55,036
+47,808
+661% +$3.46M 0.01% 1070
2020
Q3
$449K Sell
7,228
-2,984
-29% -$194K ﹤0.01% 2013
2020
Q2
$674K Sell
10,212
-11,652
-53% -$698K ﹤0.01% 1645
2020
Q1
$1.05M Buy
21,864
+10,084
+86% +$504K ﹤0.01% 1430
2019
Q4
$647K Buy
11,780
+6,776
+135% +$356K ﹤0.01% 2082
2019
Q3
$245K Buy
+5,004
New +$251K ﹤0.01% 2760
2019
Q2
Sell
-10,856
Closed -$539K 2852
2019
Q1
$539K Sell
10,856
-298,808
-96% -$13.4M ﹤0.01% 2065
2018
Q4
$11.2M Buy
309,664
+300,224
+3,180% +$12.5M 0.02% 768
2018
Q3
$481K Buy
+9,440
New +$418K ﹤0.01% 2048
2018
Q2
Sell
-5,532
Closed -$209K 2700
2018
Q1
$209K Buy
+5,532
New +$195K ﹤0.01% 2380
2015
Q3
Sell
-13,188
Closed -$325K 2150
2015
Q2
$325K Sell
13,188
-624
-5% -$15.6K ﹤0.01% 1572
2015
Q1
$346K Buy
13,812
+3,312
+32% +$78.7K ﹤0.01% 1687
2014
Q4
$243K Buy
+10,500
New +$240K ﹤0.01% 1649
2014
Q2
Sell
-10,332
Closed -$220K 1799
2014
Q1
$220K Buy
10,332
+204
+2% +$4.59K ﹤0.01% 1613
2013
Q4
$240K Buy
+10,128
New +$219K ﹤0.01% 1592

Other funds holding TECH

HSBC Holdings's TECH Position: Q1 2026 in Review

HSBC Holdings increased its Bio-Techne (TECH) stake by 6.7% in Q1 2026, buying an estimated $731K and bringing the position to 195,037 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #926.

HSBC Holdings first reported a position in TECH in Q4 2013 and has held it in 36 quarters since. The position peaked at $30.8M in Q1 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • HSBC Holdings held 195,037 shares of Bio-Techne worth $10.2M as of Q1 2026.
  • HSBC Holdings bought 12,170 Bio-Techne shares in Q1 2026, an estimated $731K.
  • Bio-Techne made up 0.01% of HSBC Holdings's portfolio in Q1 2026, its #926 holding.
  • HSBC Holdings first reported a position in Bio-Techne in Q4 2013 and has held it in 36 quarters since.
  • HSBC Holdings's Bio-Techne position peaked at $30.8M in Q1 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.